sevikar 40 mg - 5 mg filmomh. tabl.
daiichi sankyo belgium sa-nv - olmesartanmedoxomil 40 mg; amlodipinemesilaatmonohydraat 6,94 mg - eq. amlodipine 5 mg - filmomhulde tablet - 40 mg - 5 mg - olmesartanmedoxomil 40 mg; amlodipinemesilaatmonohydraat 6.94 mg - olmesartan medoxomil and amlodipine
sevikar 40 mg - 10 mg filmomh. tabl.
daiichi sankyo belgium sa-nv - olmesartanmedoxomil 40 mg; amlodipinemesilaatmonohydraat 13,89 mg - eq. amlodipine 10 mg - filmomhulde tablet - 40 mg - 10 mg - olmesartanmedoxomil 40 mg; amlodipinemesilaatmonohydraat 13.89 mg - olmesartan medoxomil and amlodipine
nexpovio
stemline therapeutics b.v. - selinexor - multiple myeloma - antineoplastische middelen - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
sevikar hct 20 mg/5 mg/12,5 mg filmomhulde tabletten
amlodipinebesilaat samenstelling overeenkomend met ; amlodipine ; hydrochloorthiazide ; olmesartanmedoxomil - filmomhulde tablet - cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; ijzeroxide zwart (e 172) ; macrogol 3350 ; magnesiumstearaat (e 470b) ; maÏszetmeel, gepregelatineerd ; polyvinylalcohol (e1203) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171)
sevikar hct 40 mg/5 mg/12,5 mg filmomhulde tabletten
amlodipinebesilaat samenstelling overeenkomend met ; amlodipine ; hydrochloorthiazide ; olmesartanmedoxomil - filmomhulde tablet - cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; ijzeroxide geel (e 172) ; macrogol 3350 ; magnesiumstearaat (e 470b) ; maÏszetmeel, gepregelatineerd ; polyvinylalcohol (e1203) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171)
sevikar hct 40 mg/5 mg/25 mg, filmomhulde tabletten
amlodipinebesilaat samenstelling overeenkomend met ; amlodipine ; hydrochloorthiazide ; olmesartanmedoxomil - filmomhulde tablet - cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; ijzeroxide geel (e 172) ; macrogol 3350 ; magnesiumstearaat (e 470b) ; maÏszetmeel, gepregelatineerd ; polyvinylalcohol (e1203) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171)
forzaten 20 mg - 5 mg (pi pharma) filmomh. tabl.
pi pharma sa-nv - olmesartanmedoxomil 20 mg; amlodipinebesilaat 6,944 mg - eq. amlodipine 5 mg - filmomhulde tablet - olmesartan medoxomil and amlodipine
forzaten 40 mg - 10 mg (pi pharma) filmomh. tabl.
pi pharma sa-nv - olmesartanmedoxomil 40 mg; amlodipinebesilaat 13,888 mg - eq. amlodipine 10 mg - filmomhulde tablet - olmesartan medoxomil and amlodipine
forzaten 40 mg - 5 mg (pi pharma) filmomh. tabl.
pi pharma sa-nv - olmesartanmedoxomil 40 mg; amlodipinebesilaat 6,944 mg - eq. amlodipine 5 mg - filmomhulde tablet - olmesartan medoxomil and amlodipine
migard 2.5 mg filmomh. tabl.
menarini international operations luxembourg s.a. - frovatriptansuccinaatmonohydraat 3,91 mg - eq. frovatriptan 2,5 mg - filmomhulde tablet - frovatriptan